Download
https://www.ndtvprofit.com/markets/goldman-says-value-not-cyclicals-would-rally-most-on-vaccine?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Value shares are a better way to bet on a Covid-19 vaccine than cyclical stocks, according to Goldman Sachs Group Inc.
Share